Navigation Links
Asterias Biotherapeutics Announces Live Investor Webcast
Date:7/24/2014

erived therapeutic cell types, research cell banks, customized reagents and equipment, and various assets relating to the AST-VAC2 program and preclinical programs in cardiology, and orthopedics.

Asterias is a member of the BioTime (NYSE MKT:BTX) family of companies.

Distribution of Series A Common Stock

As previously announced, 6,537,779 shares of Asterias Series A common stock will be distributed by Geron Corporation to its stockholders, on a pro rata basis (the "Series A Distribution"), subject to applicable legal requirements and certain other limitations, under the terms of an Asset Contribution Agreement among Asterias, BioTime, Inc., and Geron.  Fractional shares will be aggregated and sold for cash, and the net cash proceeds of the sale will be distributed ratably to Geron stockholders who would otherwise be entitled to receive fractional shares. Also, in lieu of Geron distributing the Series A common stock in jurisdictions where it would be unlawful to do so, and in certain other excluded jurisdictions, the shares of Series A common stock that Geron stockholders who reside in those jurisdictions would otherwise be entitled to receive will instead be sold for cash, and the net cash proceeds will be distributed ratably to those stockholders.

Geron has announced that it has set May 28, 2014 as the Record Date for determining Geron stockholders entitled to receive shares of Asterias Series A common stock (or cash in lieu of shares). Based on the 156,924,100 shares of Geron common stock reported by Geron as being outstanding on the Record Date, each Geron stockholder will be entitled to receive one share of Asterias Series A common stock for approximately every 24 shares of Geron common stock owned.  The Nasdaq Stock Market, where Geron common stock is traded, has established July 22, 2014 as the ex-dividend date for Geron's distribution of the Asterias Series A common stock. The Series A Distribution is expected to commen
'/>"/>

SOURCE Asterias Biotherapeutics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors
2. Agilis Biotherapeutics and Intrexon to Pursue Transformative Therapies for Rare Genetic Disease
3. Northwest Biotherapeutics to Present at the Oppenheimer 24th Annual Healthcare Conference On December 10, 2013
4. Northwest Biotherapeutics Announces Pricing Of Public Offering Of Common Stock And Warrants
5. Acquisitions, Project Announcements & Trend Analysis News for Oxygen Biotherapeutics, Glu Mobile, Cisco Systems, Barrick Gold, CVS Caremark
6. Oxford BioTherapeutics and Boehringer Ingelheim Enter Collaboration to Discover Novel Antibody Targets in Cancer
7. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
8. Smith & Nephew Announces Agreement To Acquire Assets Of Healthpoint Biotherapeutics
9. Northwest Biotherapeutics Appoints Pharma Industry Veteran As CEO Of German Subsidiary
10. Healthpoint Biotherapeutics To Create State-of-the-Art Cell Sciences Manufacturing Facility
11. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 2014  United Therapeutics Corporation (NASDAQ: UTHR ... as changes to Martine Rothblatt , Ph.D,s compensation ... United Therapeutics announced the promotion of Roger ... and David Zaccardelli , Pharm.D. to Executive Vice ... promotions, Dr. Rothblatt,s title will change from Chairman and ...
(Date:12/15/2014)... 2014 METTLER TOLEDO is pleased ... ParticleView V19 with PVM technology , is ... vision and measurement tool continuously captures high-resolution images ... V19 then automatically prepares a report pairing the ... and concentration changes. This compelling blend of high ...
(Date:12/15/2014)...  Origin Agritech Limited (NASDAQ GS: SEED) (" Origin ", ... seeds in China , today announced that ... ended September 30, 2014, before the market opens on Thursday, ... teleconference on January 8, 2015, at 8:00 a.m. ET / ... the results. To participate in the call, please dial +1-888-346-8982 ...
(Date:12/13/2014)... 12, 2014 Clarassance, a privately held ... new name: Therabron Therapeutics , Inc. The new ... (a type of structure in the lungs similar to ... to develop novel protein therapeutics for the treatment of ... to change the name to mark the company's escalation ...
Breaking Biology Technology:United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 3United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 4New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2Origin Agritech Limited to Announce Fiscal 2014 Annual Financial Results on January 8th, 2015 2Origin Agritech Limited to Announce Fiscal 2014 Annual Financial Results on January 8th, 2015 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... announced today that is has named Scott Canute, a former ... of Directors.   Over the course of his ... Eli Lilly,s global manufacturing operations.  Most recently, he spent more ... Operations for Genzyme, where he led a major turnaround effort. ...
... 12, 2011 - Two pivotal trials ... ulcerative colitis and Crohn,s disease - Shield ... the development and commercialisation of late-stage, mineral-derived hospital pharmaceuticals ... announced that the first patients have been treated in ...
... the search for new computing technologies, the University ... prestigious grants for cutting-edge nanoelectronics research that were ... Research Initiative (SRC-NRI) and the National Science Foundation. ... proposals each to the program," says Peter Kilpatrick, ...
Cached Biology Technology:Oncobiologics Appoints Scott Canute, Former President of Eli Lilly and Genzyme, to its Board of Directors 2Shield Therapeutics Initiates AEGIS 1 and AEGIS 2 Phase 3 Studies of ST10 2Shield Therapeutics Initiates AEGIS 1 and AEGIS 2 Phase 3 Studies of ST10 3Notre Dame researchers awarded millions to develop radically new computers 2
(Date:12/5/2014)... VIEW, Calif. , Dec. 4, 2014 /PRNewswire/ ... safety has boosted investments in new testing and ... has also given rise to a range of ... by the requirements of Generation Y, which is ... technologies. As a result, product development strategies of ...
(Date:11/21/2014)... , November 18, 2014 ... Systems Market by Systems (Video, RFID, Access Control, Intrusion ... Factories, Hotels, Banks, Government), Component Service Geography - Global ... Systems Market is projected to be around $25 Billion ... by 2020, growing at a CAGR of 8.69%. ...
(Date:11/18/2014)... -- The Secure Identity & Biometrics Association (SIBA) and ... formation of The Airport Entry and Exit Working ... Biometric Entry and Exit Solutions Framework for Airports ... BORDERPOL, the international non-profit organization that works directly ... border security, traveler and migration systems. ...
Breaking Biology News(10 mins):Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3
... multicolored, tropical bird with bright blue feathers, a dusty orange ... these birds less than 125 lives on one ... they will no longer exist. One University of Missouri researcher ... farmers and residents on the island inhabited by the kingfishers. ...
... MARC (Minority Access to Research Careers) Program has announced ... of America (GSA) 26th Fungal Genetics meeting in Pacific ... are meant to promote the entry of underrepresented minority ... basic science community and to encourage the participation of ...
... Foundation Inc (OSPFI) was awarded the first IOF-Anlene Nutrition ... ceremony that took place at the IOF World Wide ... March 20, 2011. The grant, valued ... Foundation (IOF) and Fonterra Brands, supports educational programmes and ...
Cached Biology News:MU researcher works to save one of the world's most endangered birds 2Philippine Foundation awarded grant for innovative bone health awareness program 2
Request Info...
We offer solid and solution phase peptide synthesis including a whole range of modifications. Please send the details of your peptide synthesis need to info@rpeptide.com...
Maxi 14 Hybridization Oven. 14 bottle (35 mm) rotisserie + shaker tray available for simultaneous use. Includes linear and orbital shaker trays, 4 medium bottles, pack of mesh, bottle gripper and d...
Request Info...
Biology Products: